Literature DB >> 34686893

A review of migraine genetics: gathering genomic and transcriptomic factors.

Andreia Dias1,2, Tiago Mariz2, Alda Sousa1,2, Carolina Lemos1,2, Miguel Alves-Ferreira3,4.   

Abstract

Migraine is a common and complex neurologic disorder that affects approximately 15-18% of the general population. Although the cause of migraine is unknown, some genetic studies have focused on unravelling rare and common variants underlying the pathophysiological mechanisms of this disorder. This review covers the advances in the last decade on migraine genetics, throughout the history of genetic methodologies used, including recent application of next-generation sequencing techniques. A thorough review of the literature interweaves the genomic and transcriptomic factors that will allow a better understanding of the mechanisms underlying migraine pathophysiology, concluding with the clinical utility landscape of genetic information and future consideration to creating a new frontier toward advancing the field of personalized medicine.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34686893     DOI: 10.1007/s00439-021-02389-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  73 in total

Review 1.  Migraine: multiple processes, complex pathophysiology.

Authors:  Rami Burstein; Rodrigo Noseda; David Borsook
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

2.  Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.

Authors:  Dawn C Buse; Elizabeth W Loder; Jennifer A Gorman; Walter F Stewart; Michael L Reed; Kristina M Fanning; Daniel Serrano; Richard B Lipton
Journal:  Headache       Date:  2013-06-28       Impact factor: 5.887

Review 3.  The pathophysiology of migraine: implications for clinical management.

Authors:  Andrew Charles
Journal:  Lancet Neurol       Date:  2017-12-08       Impact factor: 44.182

4.  Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1.

Authors:  Verneri Anttila; Hreinn Stefansson; Mikko Kallela; Unda Todt; Gisela M Terwindt; M Stella Calafato; Dale R Nyholt; Antigone S Dimas; Tobias Freilinger; Bertram Müller-Myhsok; Ville Artto; Michael Inouye; Kirsi Alakurtti; Mari A Kaunisto; Eija Hämäläinen; Boukje de Vries; Anine H Stam; Claudia M Weller; Axel Heinze; Katja Heinze-Kuhn; Ingrid Goebel; Guntram Borck; Hartmut Göbel; Stacy Steinberg; Christiane Wolf; Asgeir Björnsson; Gretar Gudmundsson; Malene Kirchmann; Anne Hauge; Thomas Werge; Jean Schoenen; Johan G Eriksson; Knut Hagen; Lars Stovner; H-Erich Wichmann; Thomas Meitinger; Michael Alexander; Susanne Moebus; Stefan Schreiber; Yurii S Aulchenko; Monique M B Breteler; Andre G Uitterlinden; Albert Hofman; Cornelia M van Duijn; Päivi Tikka-Kleemola; Salli Vepsäläinen; Susanne Lucae; Federica Tozzi; Pierandrea Muglia; Jeffrey Barrett; Jaakko Kaprio; Markus Färkkilä; Leena Peltonen; Kari Stefansson; John-Anker Zwart; Michel D Ferrari; Jes Olesen; Mark Daly; Maija Wessman; Arn M J M van den Maagdenberg; Martin Dichgans; Christian Kubisch; Emmanouil T Dermitzakis; Rune R Frants; Aarno Palotie
Journal:  Nat Genet       Date:  2010-08-29       Impact factor: 38.330

Review 5.  Pharmacogenetic considerations for migraine therapies.

Authors:  Matilde Capi; Giovanna Gentile; Luana Lionetto; Gerardo Salerno; Fabiola Cipolla; Martina Curto; Marina Borro; Paolo Martelletti
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-11-01       Impact factor: 4.481

6.  Genome-wide meta-analysis identifies new susceptibility loci for migraine.

Authors:  Verneri Anttila; Bendik S Winsvold; Padhraig Gormley; Tobias Kurth; Francesco Bettella; George McMahon; Mikko Kallela; Rainer Malik; Boukje de Vries; Gisela Terwindt; Sarah E Medland; Unda Todt; Wendy L McArdle; Lydia Quaye; Markku Koiranen; M Arfan Ikram; Terho Lehtimäki; Anine H Stam; Lannie Ligthart; Juho Wedenoja; Ian Dunham; Benjamin M Neale; Priit Palta; Eija Hamalainen; Markus Schürks; Lynda M Rose; Julie E Buring; Paul M Ridker; Stacy Steinberg; Hreinn Stefansson; Finnbogi Jakobsson; Debbie A Lawlor; David M Evans; Susan M Ring; Markus Färkkilä; Ville Artto; Mari A Kaunisto; Tobias Freilinger; Jean Schoenen; Rune R Frants; Nadine Pelzer; Claudia M Weller; Ronald Zielman; Andrew C Heath; Pamela A F Madden; Grant W Montgomery; Nicholas G Martin; Guntram Borck; Hartmut Göbel; Axel Heinze; Katja Heinze-Kuhn; Frances M K Williams; Anna-Liisa Hartikainen; Anneli Pouta; Joyce van den Ende; Andre G Uitterlinden; Albert Hofman; Najaf Amin; Jouke-Jan Hottenga; Jacqueline M Vink; Kauko Heikkilä; Michael Alexander; Bertram Muller-Myhsok; Stefan Schreiber; Thomas Meitinger; Heinz Erich Wichmann; Arpo Aromaa; Johan G Eriksson; Bryan Traynor; Daniah Trabzuni; Elizabeth Rossin; Kasper Lage; Suzanne B R Jacobs; J Raphael Gibbs; Ewan Birney; Jaakko Kaprio; Brenda W Penninx; Dorret I Boomsma; Cornelia van Duijn; Olli Raitakari; Marjo-Riitta Jarvelin; John-Anker Zwart; Lynn Cherkas; David P Strachan; Christian Kubisch; Michel D Ferrari; Arn M J M van den Maagdenberg; Martin Dichgans; Maija Wessman; George Davey Smith; Kari Stefansson; Mark J Daly; Dale R Nyholt; Daniel Chasman; Aarno Palotie
Journal:  Nat Genet       Date:  2013-06-23       Impact factor: 38.330

Review 7.  Polygenic risk score: use in migraine research.

Authors:  Mona Ameri Chalmer; Ann-Louise Esserlind; Jes Olesen; Thomas Folkmann Hansen
Journal:  J Headache Pain       Date:  2018-04-05       Impact factor: 7.277

Review 8.  Exploring the Hereditary Nature of Migraine.

Authors:  Charlene Bron; Heidi G Sutherland; Lyn R Griffiths
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-22       Impact factor: 2.570

Review 9.  Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users' views.

Authors:  Gabrielle Bertier; Martin Hétu; Yann Joly
Journal:  BMC Med Genomics       Date:  2016-08-11       Impact factor: 3.063

10.  Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy.

Authors:  Anne-Karin Arndt; Sebastian Schafer; Jorg-Detlef Drenckhahn; M Khaled Sabeh; Eva R Plovie; Almuth Caliebe; Eva Klopocki; Gabriel Musso; Andreas A Werdich; Hermann Kalwa; Matthias Heinig; Robert F Padera; Katharina Wassilew; Julia Bluhm; Christine Harnack; Janine Martitz; Paul J Barton; Matthias Greutmann; Felix Berger; Norbert Hubner; Reiner Siebert; Hans-Heiner Kramer; Stuart A Cook; Calum A MacRae; Sabine Klaassen
Journal:  Am J Hum Genet       Date:  2013-06-13       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.